세계의 체성분 분석기 시장 - 규모, 점유율, 동향 : 제품별, 모달리티별, 용도별, 유통채널별 예측(-2029년)
Body Composition Analyzers Market Size, Share & Trends by Products, Modality, Application, Distribution Channel - Global Forecasts to 2029
상품코드:1496682
리서치사:MarketsandMarkets
발행일:2024년 06월
페이지 정보:영문 280 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
전 세계 체성분 분석기 시장 규모는 2024년에 약 8억 달러이며, 2029년까지 12억 달러에 이를 것으로 예측되며, 예측기간에 CAGR로 9.3%의 성장이 예상됩니다.
체성분 분석기는 병원, 클리닉, 피트니스, 웰니스 센터, 학술 및 연구센터, 홈 사용자가 널리 사용합니다. 또한 개인의 신체 조성 데이터를 기반으로 피트니스 프로그램을 모니터링하고 조정하는 데에도 사용됩니다. 아시아태평양과 같은 신흥 시장은 체성분 분석기 시장에 유리한 성장 기회를 제공합니다.
조사 범위
조사 대상년도
2022-2029년
기준년
2023년
예측 기간
2024-2029년
단위
금액(달러)
부문
제품 유형별, 모달리티별, 사용 유형별, 용도별, 유통 채널별, 최종 사용자별
대상 지역
북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카, GCC 국가
"제품별로는 생체 임피던스 분석기 부문이 예측 기간에 시장에서 가장 높은 성장률이 되었습니다."
시장에서 생체 임피던스 분석기 부문은 상당한 성장을 보여줍니다. 이 부문의 주요 성장 촉진요인은 정확성과 신뢰성, 사용 편의성을 높이기 위해 생체 임피던스 기술의 지속적인 개선 등입니다.
"최종 사용자별로 피트니스 웰니스 센터 부문은 예측 기간 동안 시장에서 가장 높은 성장률이 되었습니다."
피트니스 클럽과 웰니스 센터는 체성분 분석기를 이용하여 고객에게 맞는 교육 및 영양 플랜을 만들고 프로그램의 효과를 높이고 있습니다. 이러한 맞춤형 접근법은 개인 피트니스 효과와 전반적인 웰빙 최적화에 도움이 됩니다.
"아시아태평양: 체성분 분석기 시장에서 가장 급성장하고 있는 지역"
아시아태평양시장이 예측기간에 가장 높은 성장률을 기록할 전망입니다. 이것은 주로 급속한 도시화와 앉기 쉬운 생활 습관이나 식생활의 혼란 등의 라이프 스타일의 변화가 이 지역에서의 체성분 분석기 수요를 촉진하고 있기 때문입니다. 이러한 장비는 효과적인 건강 관리 솔루션에 대한 필요성 증가를 반영하는 신체 조성에 대한 자세한 지식을 제공함으로써 새로운 건강 문제를 해결하는 데 도움이 됩니다.
이 보고서는 세계의 체성분 분석기 시장에 대한 조사 분석을 통해 주요 촉진요인과 억제요인, 경쟁 구도, 미래 동향 등의 정보를 제공합니다.
목차
제1장 서론
제2장 조사 방법
제3장 주요 요약
제4장 중요 인사이트
체성분 분석기 시장 개요
체성분 분석기 시장 :지역별
북미의 체성분 분석기 시장 :제품별, 국가별(2023년)
지리적 성장 기회
제5장 시장 개요
소개
시장 역학
성장 촉진요인
억제요인
기회
과제
가격 분석
주요 기업의 평균 판매 가격 동향 : 지역별
평균 판매 가격의 동향 :제품 유형별
밸류체인 분석
공급망 분석
Porter's Five Forces 분석
생태계 분석
규제기관, 정부기관, 기타 조직
규제 분석
북미
유럽
아시아태평양
특허 분석
고객의 비즈니스에 영향을 미치는 동향/혼란
주요 컨퍼런스 및 이벤트(2024-2025년)
기술 분석
주요 기술
인접 기술
주요 이해관계자와 구매 기준
무역 분석
투자와 자금조달 시나리오
체성분 분석기 시장에 대한 생성형 AI의 영향
제6장 체성분 분석기 시장 : 제품별
소개
생체 임피던스 분석기
멀티 주파수 바이오 임피던스 분석기
단일 주파수 바이오 임피던스 분석기
듀얼 주파수 바이오 임피던스 분석기
듀얼 에너지 X선 흡수 측정기
피하 지방 측정기
공기 치환식 맥파 측정기
정수역학적 계량기
제7장 체성분 분석기 시장 : 모달리티별
소개
휴대식 체성분 분석기
고정식/탁상체성분 분석기
제8장 체성분 분석기 시장 : 사용 유형별
소개
업무용 체성분 분석기
소비자용 체성분 분석기
제9장 체성분 분석기 시장 : 용도별
소개
신체 부위 측정
전신 측정
제10장 체성분 분석기 시장 : 유통 채널별
소개
오프라인/소매점
전자상거래
제11장 체성분 분석기 시장 : 최종 사용자별
소개
피트니스 클럽, 웰니스 센터
병원, 진료소
학술·연구센터
홈 사용자
제12장 체성분 분석기 시장 :지역별
소개
북미
북미에 대한 불황의 영향
미국
캐나다
유럽
유럽에 대한 불황의 영향
독일
프랑스
영국
이탈리아
스페인
기타 유럽
아시아태평양
아시아태평양에 대한 불황의 영향
일본
중국
인도
기타 아시아태평양
라틴아메리카
라틴아메리카에 대한 불황의 영향
브라질
멕시코
기타 라틴아메리카
중동 및 아프리카
GCC 국가
GCC 국가 : 경기후퇴의 영향
사우디아라비아(KSA)
아랍에미리트(UAE)(UAE)
기타 GCC 국가
제13장 경쟁 구도
개요
주요 기업의 전략/유력 기업
수익 분석
시장 점유율 분석
기업 평가 매트릭스: 주요 기업(2023년)
기업의 평가 매트릭스: 스타트업/중소기업(2023년)
평가 및 재무 지표
브랜드/제품 비교
경쟁 시나리오
제14장 기업 프로파일
주요 기업
OMRON CORPORATION
HOLOGIC, INC.
GE HEALTHCARE
INBODY CO., LTD.
RJL SYSTEMS
COSMED SRL
SECA GMBH & CO. KG.
TANITA CORPORATION
CHARDER ELECTRONIC CO, LTD.
SELVAS HEALTHCARE, INC.
EVOLT
기타 기업
MALTRON INTERNATIONAL LTD.
TONGFANG HEALTH TECHNOLOGY(BEIJING) CO., LTD.
BIOTEKNA
FOOK TIN TECHNOLOGIES LTD.
BIODYNAMICS CORPORATION
BIOPARHOM
MICROLIFE CORPORATION
NUMED SARL
SHANGHAI GOLDENWELL MEDICAL TECHNOLOGY CO., LTD.
SAMCO MEDICAL
SWISSRAY
OSTEOSYS CORP.
EXERTECH
AKERN SRL
WITHINGS
제15장 부록
JHS
영문 목차
영문목차
The body composition analyzers market is valued at an estimated USD 0.8 billion in 2024 and is projected to reach USD 1.2 billion by 2029 at a CAGR of 9.3% during the forecast period. Body composition analyzers is widely used by hospitals & clinics, fitness and wellness centers, academic & research centers and home users. It is also used in monitoring and tailoring fitness programs based on individual body composition data. Emeriging markets such as Asia Pacific region offer lucrative growth opportunities for body composition analyzers market.
Scope of the Report
Years Considered for the Study
2022-2029
Base Year
2023
Forecast Period
2024-2029
Units Considered
Value (USD)
Segments
By Product, modality, usage type, application, distribution channel and end user
Regions covered
North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
"Bioimpedance analyzers segment accounted for the highest growth rate in the body composition analyzers market, by product, during the forecast period."
The body composition analyzers market is bifurcated into bioimpedance analyzers, dual-energy X-ray absorptiometry equipment, skinfold calipers, air displacement plethysmography equipment, and hydrostatic weighing equipment. Bioimpedance analyzers segment in the body composition analyzers market is experiencing substantial growth. Major factors driving the growth of this segment include continuous improvements in bioimpedance technology to enhance accuracy, reliability, and user-friendliness.
"Fitness and wellness centers segment accounted for the highest growth rate in the body composition analyzers market, by end users, during the forecast period."
The body composition analyzers market is bifurcated into into hospitals & clinics, fitness clubs and wellness centers, academic & research centers and home users. Fitness clubs and wellness centers use body composition analyzers to create personalized training and nutrition plans for clients, enhancing program effectiveness. These tailored approaches help optimize individual fitness outcomes and overall wellness.
"Asia Pacific: The fastest-growing region body composition analyzers market."
The worldwide market for human identification is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. Notably, the Asia Pacific region market is expected to register the highest growth rate during the forecast period, mainly due to the rapid urbanization and lifestyle changes, such as sedentary habits and poor diets, are driving demand for body composition analyzers in the region. These devices help address emerging health concerns by providing detailed insights into body composition which reflects the growing need for effective health management solutions.
The break-up of the profile of primary participants in the body composition analyzers market:
By Company Type: Tier 1 - 20%, Tier 2 - 45%, and Tier 3 - 35%
By Designation: C-level - 30%, D-level - 20%, and Others - 50%
By Region: North America - 36%, Europe - 25%, Asia Pacific - 27%, Rest of the World - 12%
The key players in this market are Omron Corporation (Japan), Hologic Inc. (US), GE Healthcare (US), InBody Co., Ltd. (South Korea), Cosmed S.R.L (Italy), Seca GmbH & Co. KG (Germany), Osteosys Corp (South Korea), Tanita Corporation (Japan), Evolt (Australia), RJL Systems (US), Charder Electronic Co, Ltd. (Taiwan), Samco Medical (Pakistan), BioTekna (Italy), Selvas Healthcare (South Korea), Swissray International (US), Shanghai Goldenwell Medical Technology Co., Ltd. (China), Maltron Internation Ltd. (UK), Akern (Italy), Bioparhom (France), Exertech (US), Microlife Corporation (Switzerland), Numed S.A.R.L (Lebanon), Biodynamics Corporation (US), Tongfang Health Technology Co., Ltd. (China), Fook Tin Technologies Ltd. (Hongkong), and Withings (France).
Research Coverage:
This research report categorizes the body composition analyzers market by product (Bioimpedance Analyzers (Multi-frequency Bioimpedance Analyzers, Single-frequency Bioimpedance Analyzers, Dual-frequency Bioimpedance Analyzers), Dual-energy X-ray Absorptiometry Equipment, Skinfold Calipers, Air Displacement Plethysmography Equipment, and Hydrostatic Weighing Equipment), by modality (Portable Body Composition Analyzers, and Stationary/Benchtop Body Composition Analyzers), by usage type (Professional-Grade Body Composition Analyzers, and Consumer-Grade Body Composition Analyzers), by application (Segmental Body Measurement, and Whole-body Measurement), by distribution channel (e-commerce, and Offline/Retail Stores), by end users (Hospitals & Clinics, Fitness Clubs and Wellness Centers, Academic & Research Centers, and Home Users) and by region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the body composition analyzers market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches and recent developments associated with the body composition analyzers market. Competitive analysis of upcoming startups in the body composition analyzers market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall body composition analyzers market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
Analysis of key drivers (Growing prevalence of obesity and subsequent rise in metabolic disorders, and supportive government initiatives for healthcare awareness), restraints (high cost of equipment and availability of alternative methods), opportunities (Increasing establishment of fitness clubs and healthcare centers, integration of wearable healthcare devices with bioimpedance analyzers, Increasing adoption of self-monitoring devices) and challenges (Accuracy concerns associated with analyzers, and limited awareness in emerging markets) influencing the growth of the body composition analyzers market.
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the body composition analyzers market.
Market Development: Comprehensive information about lucrative markets - the report analyses the body composition analyzers market across varied regions.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the body composition analyzers market
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Omron Corporation (Japan), Hologic Inc. (US), and GE Healthcare (US).
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS AND EXCLUSIONS
TABLE 1 BODY COMPOSITION ANALYZERS MARKET: INCLUSIONS AND EXCLUSIONS
1.4 MARKET SCOPE
1.4.1 MARKET SEGMENTATION
FIGURE 1 BODY COMPOSITION ANALYZERS MARKET: MARKET SEGMENTS COVERED
1.4.2 REGIONAL SEGMENTATION
FIGURE 2 BODY COMPOSITION ANALYZERS MARKET: REGIONS COVERED
1.4.3 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 3 BODY COMPOSITION ANALYZERS MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key industry insights
2.1.2.3 Key data from primary sources
2.1.2.4 Breakdown of primary interviews
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.2.1.2 Approach 2: Presentations of companies and primary interviews
2.2.1.3 Approach 3: Demand-side analysis
2.2.1.4 Growth forecast
2.2.1.5 CAGR projections
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2.2 TOP-DOWN APPROACH
FIGURE 7 BODY COMPOSITION ANALYZERS MARKET: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE
2.5 STUDY ASSUMPTIONS
FIGURE 9 BODY COMPOSITION ANALYZERS MARKET: STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 BODY COMPOSITION ANALYZERS MARKET: RISK ASSESSMENT ANALYSIS
2.8 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 10 BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 11 BODY COMPOSITION ANALYZERS MARKET, BY MODALITY, 2024 VS. 2029 (USD MILLION)
FIGURE 12 BODY COMPOSITION ANALYZERS MARKET, BY USAGE TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 13 BODY COMPOSITION ANALYZERS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 14 BODY COMPOSITION ANALYZERS MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD MILLION)
FIGURE 15 BODY COMPOSITION ANALYZERS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 16 BODY COMPOSITION ANALYZERS MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 BODY COMPOSITION ANALYZERS MARKET OVERVIEW
FIGURE 17 RISING PREVALENCE OF OBESITY AND SUBSEQUENT RISE IN METABOLIC DISORDERS TO DRIVE MARKET
4.2 BODY COMPOSITION ANALYZERS MARKET, BY REGION
FIGURE 18 BIOIMPEDANCE ANALYZERS SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.3 NORTH AMERICA: BODY COMPOSITION ANALYZERS MARKET, BY PRODUCT AND COUNTRY (2023)
FIGURE 19 BIOIMPEDANCE ANALYZERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
4.4 GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 20 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 BODY COMPOSITION ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of obesity and subsequent rise in metabolic disorders
5.2.1.2 Supportive government initiatives for healthcare awareness
5.2.2 RESTRAINTS
5.2.2.1 High cost of equipment
5.2.2.2 Availability of alternative products
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing establishment of fitness clubs and healthcare centers
5.2.3.2 Integration of wearable healthcare devices with bioimpedance analyzers
5.2.3.3 Growing adoption of self-monitoring devices
5.2.4 CHALLENGES
5.2.4.1 Accuracy concerns associated with analyzers
5.2.4.2 Limited awareness in emerging markets
5.3 PRICING ANALYSIS
5.3.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION
5.3.2 AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE
5.4 VALUE CHAIN ANALYSIS
FIGURE 22 BODY COMPOSITION ANALYZERS MARKET: VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 23 BODY COMPOSITION ANALYZERS MARKET: SUPPLY CHAIN ANALYSIS
5.6 PORTER'S FIVE FORCES ANALYSIS
TABLE 3 BODY COMPOSITION ANALYZERS MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 24 BODY COMPOSITION ANALYZERS MARKET: PORTER'S FIVE FORCES ANALYSIS
5.6.1 INTENSITY OF COMPETITIVE RIVALRY
5.6.2 BARGAINING POWER OF SUPPLIERS
5.6.3 BARGAINING POWER OF BUYERS
5.6.4 THREAT OF NEW ENTRANTS
5.6.5 THREAT OF SUBSTITUTES
5.7 ECOSYSTEM ANALYSIS
FIGURE 25 BODY COMPOSITION ANALYZERS MARKET: ECOSYSTEM MARKET/MAP
5.7.1 BODY COMPOSITION ANALYZERS MARKET: ROLE IN ECOSYSTEM
5.8 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9 REGULATORY ANALYSIS
5.9.1 NORTH AMERICA
5.9.1.1 US
TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION
5.9.1.2 Canada
TABLE 6 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.9.2 EUROPE
5.9.3 ASIA PACIFIC
5.9.3.1 Japan
TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
*Business Overview, Products/Services/Solutions Offered, Recent Developments, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats might not be captured in case of unlisted companies.
14.2 OTHER PLAYERS
14.2.1 MALTRON INTERNATIONAL LTD.
TABLE 352 MALTRON INTERNATIONAL LTD.: COMPANY OVERVIEW
14.2.2 TONGFANG HEALTH TECHNOLOGY (BEIJING) CO., LTD.
TABLE 353 TONGFAND HEALTH TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW
14.2.3 BIOTEKNA
TABLE 354 BIOTEKNA: COMPANY OVERVIEW
14.2.4 FOOK TIN TECHNOLOGIES LTD.
TABLE 355 FOOK TIN TECHNOLOGIES LTD.: COMPANY OVERVIEW
14.2.5 BIODYNAMICS CORPORATION
TABLE 356 BIODYNAMICS CORPORATION: COMPANY OVERVIEW
14.2.6 BIOPARHOM
TABLE 357 BIOPARHOM: COMPANY OVERVIEW
14.2.7 MICROLIFE CORPORATION
TABLE 358 MICROLIFE CORPORATION: COMPANY OVERVIEW
14.2.8 NUMED S.A.R.L.
TABLE 359 NUMED S.A.R.L.: COMPANY OVERVIEW
14.2.9 SHANGHAI GOLDENWELL MEDICAL TECHNOLOGY CO., LTD.
TABLE 360 SHANGHAI GOLDENWELL MEDICAL TECHNOLOGY CO. LTD.: COMPANY OVERVIEW
